Table 2.
Summary of quality assessments for individual articles included in the systematic review.
| Author, Year | Was the Study Described as Randomized? | Was the Randomization Appropriate? | Was the Study Described as Double-Blind? | Was the Blinding Appropriate? | Were the Dropouts Justified? | Was There a Clear Description of Inclusion and Exclusion Criteria? | Has the Method to Capture Adverse Events Been Described? | Has the Method of Statistical Analysis Been Described? | Jadad Score | Modified Jadad Score |
|---|---|---|---|---|---|---|---|---|---|---|
| Andresen 2016 [27] | ● | ● | ● | ○ | ● | ● | ● | ● | 4 | 7 |
| Cobellis 2011 [29] | ● | ● | ● | ○ | ○ | ● | ○ | ● | 3 | 5 |
| Cremon 2017 [25] | ● | ● | ● | ● | ● | ● | ○ | ● | 5 | 7 |
| Faig-Marti 2017 [30] | ● | ○ | ● | ○ | ● | ● | ○ | ● | 3 | 5 |
| Marini 2012 [31] | ● | ● | ● | ● | ○ | ● | ● | ● | 4 | 7 |
| Murina 2013 [32] | ● | ● | ● | ○ | ● | ● | ○ | ● | 4 | 6 |
| Orefice 2016 [28] | ● | ● | ● | ○ | ○ | ● | ● | ● | 3 | 6 |
| Ottaviani 2019 [33] | ● | ● | ● | ○ | ● | ● | ○ | ● | 4 | 6 |
| Pickering 2022 [34] | ● | ● | ● | ● | ● | ● | ● | ● | 5 | 8 |
| Steels 2019 [26] | ● | ● | ● | ● | ● | ● | ● | ● | 5 | 8 |
| Tartaglia 2017 [35] | ● | ○ | ○ | ○ | ● | ● | ○ | ● | 3 | 5 |
Legend: ● = yes, ○ = no.